Back
TuHURA Biosciences, Inc. HURA · Insights
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registrati... Price1.66
Market Cap110.6 M
Float45.2 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro